Yipeng Du

Scientist II at Lucy Therapeutics

Yipeng brings over 10 years experience in the field of mitochondrial research to Lucy Therapeutics. He has published over 16 peer-reviewed articles and has centered his work on how mitochondria is linked to metabolic diseases. Yipeng is focusing on developing a series of mitochondrial platforms for drug screening.

Links

Timeline

  • Scientist II

    Current role

View in org chart